Stocksigma LogoStocksigma Logo

CARE Reaffirms Dhampur Bio Organics Ratings; Outlook Revised to Positive

CARE Ratings reaffirmed Dhampur Bio Organics' long-term bank facilities at CARE BBB+ and short-term facilities at CARE A2, revising the long-term outlook

CARE Reaffirms Dhampur Bio Organics Ratings; Outlook Revised to Positive

Dhampur Bio Organics Ltd · Others (Uncategorized) · 05 Sept 2026, 6:15 pm

CARE Reaffirms Dhampur Bio Organics Ratings; Outlook Revised to Positive CARE Ratings reaffirmed Dhampur Bio Organics' long-term bank facilities at CARE BBB+ and short-term facilities at CARE A2, revising the long-term outlook from Stable to Positive. The outlook revision reflects an improving financial risk profile driven by debt reduction from proceeds of the Meerganj unit slump sale for ₹305 crore in Jun'26. Long-term debt declined to ₹125 crore as of 31st Jul'26 from ₹290 crore on 31st Mar'26. Consequently, net leverage is projected to drop below 5.5x by FY27-end, supported by firm sugar prices.

Original exchange filing (PDF)

More announcements from Dhampur Bio Organics Ltd

All Dhampur Bio Organics Ltd announcements